Cannabis Chronicles

JANUARY 30, 2019

— writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. Not everyone in the field of cannabis and cannabinoid research was put off by the articles.

Marijuana 124

Marijuana Data Cannabinoids Medicine 124

CannaMD

JULY 8, 2020

The authors note that marijuana cannabinoids, THC and CBD , appear to have antidepressant-like effects in animal models, and report that in human surveys: Medical cannabis users perceived a 50% reduction in depression and a 58% reduction in anxiety and stress following cannabis use.

Marijuana 111

Marijuana Research and Development Conditions THC 111

Veriheal

FEBRUARY 28, 2021

Could cannabinoid therapies have helped my little man? Alexis suffers from a rare condition called Dravet syndrome epilepsy. The science behind cannabinoid therapies is advancing thanks to legalization. Cannabinoid medicine is not guaranteed to save someone’s life or even to work for someone.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

The Cannigma

JANUARY 30, 2022

After spending five years interviewing women about their sexual desires, sociologist Kathleen Rowland reported that the “pleasure gap” between men and women is “neither medical malady nor psychological condition but rather a result of our culture’s troubled relationship with women’s sexual expression.”. How does it work?

Strains 143

Strains Edibles Terpenes Topical 143

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Greencamp

NOVEMBER 9, 2018

Around 1200 BC, ancient Egyptians used the herb to treat many conditions, including asthma. Also, young adults between the ages of 18 to 24 are more likely to be diagnosed with the condition than older adults. Sadly, there is no permanent cure for this condition, but there are a few types of treatments to keep it under control.

Research and Development 92

Research and Development Edibles Patients Cannabinoids 92

Greencamp

DECEMBER 4, 2018

Nonetheless, the available collection of scientific work confirms that consuming cannabis-derived cannabinoids (phytocannabinoids) compels our body to produce more (endo)cannabinoid receptors, but also to create more endocannabinoids. These receptors are located on the membranes of many different cells, spread throughot the body.

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

The Cannigma

AUGUST 26, 2021

This represents nearly double the level of support found in a 2007 survey (21%). According to the Commonwealth Department of Health , Nabiximols (a cannabinoid spray marketed as Sativex) is the only cannabis product that is considered a registered medicine in the country. Qualifying conditions for medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Greencamp

APRIL 23, 2019

According to MS Society of Canada , 1 in every 385 Canadians lives with this condition. As it’s one of the most debilitating conditions, living with multiple sclerosis is a real battle. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist.

Research and Development 94

Research and Development Strains Patients Treatment 94

Alchimia

MARCH 16, 2016

Cannabinoids represent a new and interesting option to prevent and impede the development of symptoms of Alzheimer , since they act differently against this pathology: They reduce aggregation of beta-amyloid peptide, which is the main indicator of Alzheimer’s disease. How does cannabis combat Alzheimer’s disease? Cannabis patient.

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Green Relief

FEBRUARY 20, 2018

Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Immune system pathways (for targeted cannabinoid therapy) 12. 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

FEBRUARY 19, 2018

Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Immune system pathways (for targeted cannabinoid therapy) 12. 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

Cannabis Law Report

JULY 8, 2021

million) and 2007. These unfavourable findings vastly outnumber known benefits for a small number of medical conditions for which effective and safe alternatives are readily available. percent or 16.7 million) than in 2008 (6.1 percent or 15.2 percent or 14.4 Tax Revenue Implications. Legalisation or Decriminalisation of Cannabis .

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Medical publications, are, in the main fairly positive toward cannabis. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Freedom Leaf

JANUARY 10, 2018

Tikun Olam , which was founded in 2007, controls nearly 40% of the Israeli medical-marijuana market. We genetically develop [the strains] to improve patients’ symptoms and conditions,” Gardner explains. “In In the United States, it already has retail outposts in Nevada and Delaware. . But, in the U.S.,

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Corante

FEBRUARY 26, 2020

The potency of the crop is dependent on several factors, including the interaction between the terpenes, cannabinoids, and flavonoids of the strain. Along with greater availability comes greater potential to treat a wider variety of health conditions.

Strains 40

Strains CBD Hemp THC 40

Cannabis Law Report

OCTOBER 29, 2019

Dr. Wakshlag and ElleVet are currently conducting additional clinical trials to demonstrate the efficacy of ElleVet hemp CBD/CBDA in other important conditions. Recent medical interest in alternative therapies and modalities for pain relief has led many pet owners to seek hemp related products rich in cannabinoids. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

FEBRUARY 1, 2020

Nonetheless, medical cannabis isn’t accessible to everyone, even those with qualifying medical conditions and an authorised prescription. An official investigation in 2007 found that the majority of individuals killed during the war had no connection to drugs. However, many view the policy as a cover for arbitrary killings.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

JUNE 11, 2019

A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. A pain management specialist recommended a trial of Nabilone, the synthetic cannabinoid, or of medical marijuana. I decline to award a sum of money to permit the plaintiff to experiment with cannabinoids; … 23. Fabretti v.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

The Cannigma

APRIL 7, 2022

I mean, we’re just discovering the TRP Channels that are involved in maybe the headache effects of cannabinoids. As a matter of fact, it’s gotten to the point where now I consider a lot of terpenes to be what I call window pane terpenes, and because you’re seeing through them to the cannabinoids behind them.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

SpeedWeed

FEBRUARY 19, 2021

Egyptian medical applications of cannabis show an astute knowledge of the efficacy of herbal remedies, and virtually all of their remedies containing it utilize it in a way in which cannabis has been known to be medically effective (Russo, 2006/2007). 3000 years under favorable conditions. Ìf the hieroglyph ‘smsm.t’

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Cannabis Law Report

NOVEMBER 23, 2019

Wechsler , 83 USPQ2d 1715, 1724 (TTAB 2007)); TMEP §1207.01(a)(i). It is reputed to have medicinal properties that some consumers use for treating medical conditions such as pain, seizures, nausea, anxiety, and cancer among other things. Triumph Learning LLC , 668 F.3d 3d 1356, 1369, 101 USPQ2d 1713, 1722 (Fed.

THC 76

THC Law Medicine Marijuana 76

SpeedWeed

MARCH 14, 2021

Carl Ruck, “Since the wine of Dionysus is a mediation between the god’s wild herbal ancestors and the civilized phenomenon of his cultivated and manufactured manifestation in the product fermented from the juice of the grape, it is most probable that this was the way in which the Greeks incorporated hemp into their pharmacopoeia” (Ruck, 2007).

Wellness and Beauty 52

Wellness and Beauty Research and Development History Hemp 52

Cannabis Law Report

MARCH 25, 2019

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). 2003, 2004, 2007, 2008, Nov. 2003, 2004, 2007, 2008, Nov. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 101–189, div.

Banking 45

Banking Law Marijuana State Laws 45